#132 | What It Really Takes To Bring a Biotech Platform To Market

#132 | What It Really Takes To Bring a Biotech Platform To Market

39:54 Jun 1, 2025
About this episode
Great science doesn’t guarantee commercial success - especially in biotech.In this episode, Hakeem sits down with Nigel Theobald, founder and CEO of N4 Pharma, to unpack what it really takes to turn an RNA delivery platform into a viable, scalable business. From investor pressure to team building and tough pivots, Nigel shares lessons every biotech or MedTech founder needs to hear.Here’s what you’ll learn: – How to go from a biotech platform to a commercial product – What it takes to build a virtual, world-class team in a capital-intensive space – How to stay resilient when timelines shift and strategies evolveIf you're building something at the edge of science and business - this episode is for you.
Select an episode
0:00 0:00